Petit mal epilepsy: A review and integration of recent information

Journal of Clinical Neurophysiology

Volumn 3, Issue 3, 1986, Pages 179-208

  Mirsky, Allan F ^a   Duncan, Connie C ^a   Myslobodsky, Michael S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Petit mal epilepsy; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

ABSENCE; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; ELECTROENCEPHALOGRAPHY; ETIOLOGY; HUMAN; PETIT MAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THERAPY;

ADOLESCENT; ADULT; ANTICONVULSANTS; BENZODIAZEPINES; BRAIN; COGNITION; DEMENTIA; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY, ABSENCE; EVOKED POTENTIALS; GAMMA-AMINOBUTYRIC ACID; HUMAN; MOTOR SKILLS; NOREPINEPHRINE; PROGNOSIS; SENSATION; SODIUM OXYBATE; VALPROIC ACID;

EID: 0022485569     PISSN: 07360258     EISSN: 15371603     Source Type: Journal    
DOI: 10.1097/00004691-198607000-00001     Document Type: Article

References (162)

1. Ackermann RF, Finch DM, Babb TL, Engel JR. Hippocampal recurrent inhibition: decreased pyramidal cell firing with reversed metabolism in the pyramidal cell layer demonstrated by the deoxyglucose autoradiographic technique. Neurosci Abstr 1981;7:457.
2. Ajmone-Marsan C. Pathophysiology of the EEG pattern characteristic of petit mal epilepsy, a critical review of some of the experimental data. In: Gastaut H, Jasper H, Bancaud J, Waltregny A, eds. The physiopathogenesis of the epilepsies. Springfield, IL: Thomas, 1969:237-49.
3. Alfrey AC, Le Gende GR, Kochny WO. The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl J Med 1976;294:184-8.
4. Alfrey AC, Mishell JB, Burks J, Contiguglia JR, Rudolph M, Lewin ES, Holmes JM. Syndrome of dyspraxia and multifocal seizures associated with chronic haemodialysis. Trans Am Soc Artif Intern Organs 1972;18:257-61.
5. Andermann F, Robb JP. Absence status: a reappraisal following a review of 38 patients. Epilepsia 1972; 13:177.
6. Ball JM, Butkus DE, Madison DS. Effect of subtotal parathyroidectomy on dialysis dementia. Nephron 1977;18:151-5.
7. Banfi S, Fonio W, Allievi E, Raimondo S. Experimental chronic epilepsy in rats: a screening method for anti-epileptic drugs. Pharmacol Res Commun 1983;15:553-8.
8. Barker JL, Gratz E, Owen DG, Study RE. Pharmacological effects of clinically important drugs on the excitability of cultured mouse spinal neurons. In: Bowery NG, ed. Actions and interactions of GABA and benzodiazepines. New York: Raven Press, 1984;203-16.
9. Bigler ED. Diazepam modification of evoked and spontaneous lateral geniculate activity. Electroencephalogr Clin Neurophysiol 1976;41:428-33.
10. Bigler ED. Comparison of the effects of bicuculline, strychnine, and picrotoxin with pentylenetetrazol on photically evoked afterdischarges. Epilepsia 1977;18:465-70.
11. Bigler ED, Fleming DE, Shearer DE. Metrazol potentiated afterdischarges: dose-response relationship, and effects of selective lesions. Pharmacol Biochem Behav 1976;5:423-9.
12. Black JA, Golden GT, Fariello RG. Ketamine alteration of experimental cortico-reticular epilepsy. Neurology 1980;30:305-18.
13. Brooksbank BW, Atkinson DJ, Balazs R. Biochemical development of the human brain. II. Some parameters of the GABAergic system. Dev Neurosci 1981;4:188-200.
14. Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narco- lepsy-catalepsy. J Can Sci Neurol 1980;7:23-31.
15. Browne TR, Feldman R, eds. Epilepsy diagnosis and management. Toronto: Little, Brown, 1983.
16. Browne TR, Mirsky AF. Absence (petit mal) seizures. In: Browne TR, Feldman R, eds. Epilepsy diagnosis and management. Toronto: Little, Brown, 1983:61-74.
17. Browne TR, Penry JK, Porter RJ, Dreifuss FE. Responsiveness before, during, and after spike-wave paroxysms. Neurology 1974;24:659-65.
18. Buchhalter JR, Dichter MA. Effects of valproic acid in cultured mammalian neurons. Neurology 1986; 36:259-82.
19. Burchiel KJ, Myers RR, Bickford RG. Visual and auditory evoked responses during penicillin-induced generalized spike-and-wave activity in cats. Epilepsia 1976;17:293-311.
20. Burks JS, Alfrey AC, Huddlestone J, Norenberg MD, Levin E. A fatal encephalopathy in chronic haemo- dialysis patients. Lancet 1976;1:764-8.
21. Cabral JR, Scott DF. Effects of two desensitization techniques, biofeedback and relaxation on intractable epilepsy: follow-up study. J Neurol Neurosurg Psychiatry 1976;39:504-7.
22. Cautela JR, Flannery RB. Seizures: controlling the uncontrollable. J Rehabil 1973;39:34.
23. Celesia GG, Chen RC, Bamforth BJ. Effects of ketamine in epilepsy. Neurology 1975;25:169-72.
24. Charlton MH, Yahr MD. Long-term follow-up of patients with petit mal. Arch Neurol 1967;16:595-8.
25. Chugani HT, Ackermann RF, Chugani DC, Engel J Jr. Autoradiographic studies of opioid-mediates epileptogenic phenomena in rats. In: Fariello RG, Morselli PL, Lloyd KG, Quesney LF, Engel J Jr, eds. Neurotransmitters, seizures, and epilepsy II. New York: Raven Press, 1985:315-25.
26. Cobb WA, Van Duijn H, ed. Contemp Clin Neurophysiol 1978;34(EEG Suppl):577 pp.
27. Commissaris RL, Gordon JJ, Sprague S, Keiser J, Mayor GH, Rech RM. Behavioral changes in rats after chronic aluminum and parathyroid hormone administration. Neurol Behav Toxicol Teratol 1982;4: 403-10.
28. Coyle JT, Enna SJ. Neurochemical aspects of the ontogenesis of GABAergic neurons in the rat brain. Brain Res 1976;111:119-33.
29. Crain SM, Bornstein MB. Early onset in inhibitory functions during synaptogenesis in fetal mouse brain cultures. Brain Res 1974;68:351-7.
30. David J, Marathe SB, Patil SD, Grewal RS. Behavioral and electrical correlates of absence seizures induced by thalamic stimulation in juvenile rhesus monkeys with frontal aluminum hydroxide implants: a pharmacologic evaluation. J Pharmacol Methods 1982;7:219-29.
31. Dawson GD. Investigations on a patient subject to myoclonic seizures after sensory stimulation. J Neurol Neurosurg Psychiatry 1947;10:141-62.
32. Doble A, Iversen LL, Bowery NJ, Hill DR, Hudson AL. 6-Hydroxydopamine decreases benzodiazepine but not GABA receptor binding in rat cerebellum. Neurosci Lett 1982;27:199-204.
33. Doherty JD, Hattox SE, Snead OC, Roth RM. Identification of endogenous hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. J Pharmacol Exp Ther 1978;207:130-9.
34. Doherty JD, Roth RM. Identification of hydroxybutyric acid at an endogenous metabolite present in monkey and human brain. Fed Proc 1976;35:270.
35. Donchin E. Event-related brain potentials: a tool in the study of human information processing. In: Begleiter H, ed. Evoked brain potentials and behavior. New York: Plenum Press, 1979:13-88.
36. Donchin E, Ritter W, McCallum WC. Cognitive psychophysiology: the endogenous components of the ERP. In: Callaway E, Turting P, Koslow SH, eds. Event-related brain potentials in man. New York: Academic Press, 1978:349-411.
37. Dondey M. Transverse topographical analysis of petit mal discharges: diagnosticai and pathogenic implications. EEG Clin Neurophysiol 1983;55:361-71.
38. Dulac O, Arthuis MC. Open trials with valproate in epilepsy. Epilepsia 1984;25(Suppl 1):S23-31.
39. Duncan-Johnson CC, Donchin E. On quantifying surprise: the variation of event-related potentials with subjective probability. Psychophysiology 1977;14:456-67.
40. Elomaa E, Lehtovaara R, Bardy A. Do the peptide hormones common to intestine and brain participate in the genesis of epilepsy? Med Hypotheses 1978;4:189-92.
41. Engel J Jr, Ackermann RF, Caldecott-Hazard SZ, Chugani MT. Do altered opioid mechanisms play a role in human epilepsy? WONIEP 1983;II (in press).
42. Engel J Jr, Kuhl DE, Phelps ME. Pattern of human local cerebral glucose metabolism during epileptic seizures. Science 1982a;218:64-6.
43. Engel J Jr, Kuhl DE, Phelps MC, Crandell PH. Comparative localization of the epilepsy faci in partial epilepsy by PCT and EEG. Ann Neurol 1982b;12:529-7.
44. Fariello RG. Neurophysiological investigations on direct GABA agonists. In: Morselli PL, Lloyd KG, Lscher W, Meldrum B, Reynolds EG, eds. Neurotransmitters, seizures, and epilepsy. New York: Raven Press, 1981:75-83.
45. Fariello RG, Golden GT, Alexander GW, Schwartzman RJ. Metabolic correlates of GABAmimetic induced EEG abnormalities. In: Fariello RG, Morselli PL, Lloyd KG, Quesney LF, Engel J Jr, eds. Neurotransmitters, seizures, and epilepsy II. New York: Raven Press, 1984:245-52.
46. Fedio P, Mirsky AF. Selective intellectual deficits in children with temporal lobe or centrencephalic epilepsy. Neuropsychologia 1969;7:287-300.
47. Feldman RG, Paul NL. Identity of emotional triggers in epilepsy. J Nerv Ment Dis 1976;162:345-53.
48. Feldman RG, Ricks NL, Orren MM. Behavioral methods of seizure control. In: Browne TR, Feldman RG, eds. Epilepsy diagnosis and management. Toronto: Little, Brown, 1983:269-79.
49. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and nonopiate systems. Brain Res Rev 1983;6:197-210.
50. Frenk H, McCarty BC, Liebeskind JC. Different brain areas mediate the analgesic and epileptic properties of enkephalin. Science 1978a;200:335-7.
51. Frenk M, Urea G, Liebeskind JC. Epileptic properties of leucine-and methionine-enkephalin: comparison with morphine and reversibility by naloxone. Brain Res 1978b;147:327-37.
52. Geller M, Geller A. Brief amnestic effects of spike-wave discharges. Neurology 1970;20:1089-95.
53. Gibberd FB. The prognosis of petit mal epilepsy in adults. Epilepsia 1972;13:171-5.
54. Gloor P. Generalized epilepsy with bilaterally synchronous spike and wave discharge: new findings concerning its physiological mechanisms. Electroencephalogr Clin Neurophysiol 1978;34(Suppl):245-9.
55. Gloor P. Generalized epilepsy with spike-and-wave discharge: a reinterpretation of its electrographic and clinical manifestations. Epilepsia 1979;20:571-84.
56. Gloor P, Testa G. Generalized penicillin epilepsy in the cat: effects of intracarotid and intravertebral pentylenetetrazol and amobarbital injections. Electroencephalogr Clin Neurophysiol 1974;36:499-515.
57. Godbout R, Pivik RT. EEG and behavioral effects of gamma-hydroxybutyrate in the rabbit. Life Sci 1982; 31:739-98.
58. Godschalk M, Dzoljic MR, Bonta IL. Antagonism of gamma-hydroxybutyrate-induced hypersynchronization in the ECoG of the rat by anti-petit mal drugs. Neurosci Lett 1976;3:145-50.
59. Godschalk M, Dzoljic MR, Bonta IL. Slow wave sleep and a state resembling absence epilepsy induced in the rat by hydroxybutyrate. Eur J Pharmacol 1977;44:105-11.
60. 3H] hydroxybutyric acid by rat brain. J Neurochem 1977;28:1069-73.
61. Goode DJ, Penry JK, Dreifuss FE. Effects of paroxysmal spike-wave on continuous visual-motor performance. Epilepsia 1970;11:241-54.
62. Grady CL. The prediction of spike-wave bursts in the electroencephalogram by power-spectrum and coherence analysis. Unpublished Ph.D. dissertation, Order #8212Y98, 1982.
63. Gray JA. The neurophysiology of anxiety. New York: Oxford University Press, 1982.
64. Gunale SR. Dialysis dementia: asparagine deficiency? Lancet 1973;2:847.
65. Hauser F. Perception et reponses motrices au cours des paroxysms de pointes-ondes. Paris: Foulon, 1960:52 pp.
66. Heller AH. Clonidine exacerbates absence seizures in the mutant mouse tottering. Neurosci Abstr 1984; 1:123-5.
67. Henriksen O, Johannessen SI. Valproate monotherapy. Epilepsia 1984;25(Suppl 1):73-7.
68. Hughes JR, Schreeder MT. EEG in dialysis encephalopathy. Neurology 1980;30:1148-54.
69. Hunter J, Jasper HH. Effects of thalamic Stimulation in unanesthetized animals. Electroencephalogr Clin Neurophysiol 1949;1:305-24.
70. Ingvar DH. Reproduction of the 3-per-second spike and wave EEG pattern by subcortical electrical stimulation in cats. Acta Physiol Scand 1955;33:137.
71. Jasper HH, Koyama I. Rate of release of amino acids from the cerebral cortex in the cat as affected by brainstem and thalamic stimulation. Can J Physiol Pharmacol 1969;47:889-901.
72. Jeavons PM. Non-dose-related side effects of valproate. Epilepsia 1984;25(Suppl 1):S50-6.
73. 3H] GABA from rat brain slices. J Neurochem 1971;18:2441-6.
74. Jung R. Correlation of bioelectrical and autonomic phenomena with alterations of consciousness and arousal in man. In: Delafresnaye JF, ed. Brain mechanisms and consciousness. Oxford: Blackwell, 1954: 310-34.
75. Kaplan BJ. Biofeedback in epileptics: equivocal relationship of reinforced EEG frequency to seizure reduction. Epilepsia 1975;16:477-85.
76. Kelly P, McCulioch J. Effects of the putative GABAergic agonists, muscimol and THIP upon cerebral glucose utilization. J Neurochem 1982;39:613-24.
77. King A. Effects of systemically applied GABA on wave-spike EEG activity in rat. Neuropharmacology 1979;18:42-55.
78. King GA, Burnham WM. Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy. Psychopharmacology 1980;69:281-5.
79. Kozhechkin SN. The influence of sodium gamma-hydroxybutyrate on GABA. Receptors and catecholamine effects potentiation. Arch Int Pharmacodyna Ther 1981;250:242-53.
80. Kuhlman WH. EEG feedback training of epileptic patients' clinical and electrographic analysis. Electroencephalogr Clin Neurophysiol 1978;45:699-710.
81. Lansdell H, Mirsky AF. Attention in focal and centrencephalic epilepsy. Exp Neurol 1964;9:463-9.
82. Levy RH (ed). Valproate modern perspectives. Epilepsia 1984;25(Suppl 1):S1-77.
83. Loiseau P. Rational use of valproate: indications and drug regimen in epilepsy. Epilepsia 1984;25(Suppl 1):65-72.
84. Lugaresi E, Pazzaglia P, Tassinari CA. Differentiation of absence status and temporal lobe status. Epilepsia 1971;12:77.
85. Marcus EM, Watson CW. Bilateral synchronous spike wave electrographic patterns in the cat. Interaction of bilateral cortical foci in the intact, the bilateral cortico-callosal, and diencephalic, preparation. Arch Neurol 1966;14:601-10.
86. Marcus EM, Watson CW, Simon SA. An experimental model of some variations of epilepsy. Electrical- behavioral correlation of acute bilateral epileptogenic foci in cerebral cortex. Epilepsia 1968;9:233- 48.
87. Marcus RJ, Winters WD, Mori K, Spooner CE. EEG and behavioral comparison of the effects of gamma- hydroxybutyrate, gamma-butyrolactone and short chain fatty acids in the rat. Int J Neuropharmacol 1967;6:175-85.
88. Mayor GM, Keiser JA, Makdani D, Ku PK. Aluminum absorption and distribution: effect of parathyroid hormone. Science 1977;197:1187-9.
89. Meldrum B, Horton R. Effects of the bicyclic GABA agonist THIP, on myoclonic and seizure response in mice and baboons with reflex epilepsy. Eur J Pharmacol 1980;61:231-7.
90. Mirsky AF. Attention-commentary. In: Callaway E, Tueting P, Koslow SH, eds. Event-related brain potentials in man. New York: Academic Press, 1978:323-41.
91. Mirsky AF, Bloch-Rojas S, McNary WF. Experimental petit mal epilepsy produced with chlorambucil. Arch Biol Exp (Warsaw) 1966;26:55-61.
92. Mirsky AF, Bloch-Rojas S, Tecce JJ, Lessell S, Marcus E. Visual evoked potentials during experimentally induced spike-wave activity in monkeys. Electroencephalogr Clin Neurophysiol 1973;35:25-37.
93. Mirsky AF, Orren MM. Attention. In: Miller LH, Sandman CA, Kastin AJ, eds. Neuropeptide influences on the brain and behavior. New York: Raven Press, 1977:233-67.
94. Mirsky AF, Orren MM, Stanton L, Fullerton B, Harris S, Myers RE. Auditory evoked potentials and auditory behavior following prenatal and perinatal asphyxia in rhesus monkeys. Dev Psychobiol 1979;12: 369-79.
95. Mirsky AF, Oshima HI. Effect of subcortical aluminum cream lesions on attentive behavior and the electroencephalogram in monkeys. Exp Neurol 1973;39:1-18.
96. Mirsky AF, Primae DW, Ajmone-Marsan C, Rosvold HE, Stevens JA. A comparison of the psychological test performance of patients with focal and nonfocal epilepsy. Exp Neurol 1960;2:75-89.
97. Mirsky AF, Tecce JJ. The analysis of visual evoked potentials during spike and wave EEG activity. Epilepsia 1968;9:211-20.
98. Mirsky AF, Van Buren JM. On the nature of the absence in centrencephalic epilepsy: a study of some behavioral, electroencephalic and autonomic factors. Electroencephalogr Clin Neurophysiol 1965; 18:334-48.
99. Moroni F, Bianchi C, Tangenelli S, Spidalieri G, Guandalini P, Beani L. Intracerebroventricular noradrenaline or locus ceruleus stimulation increase the output of GABA and decrease that of acetylcholine from guinea pig cerebral cortex. Paper presented at the 4th European Neuroscience Meeting. Neurosci Lett 1980.
100. Moroni F, Corradetti R, Casamenti F, Moneti G, Pepeu G. The release of endogenous GABA and glutamate from the cerebral cortex in the rat. Naunyn Schmiedebergs Arch Pharmacol 1981;316:235-9.
101. Myslobodsky MS. Petit mal epilepsy. New York: Academic Press, 1976.
102. Myslobodsky MS, Ackermann RF, Engel J Jr. Effect of acetylenic GABA and vinyl GABA on metra- zol-activated and kindled seizures. Pharmacol Biochem Behav 1979a;11:265-71.
103. Myslobodsky MS, Ackermann R, Golovchinsky V, Engel J Jr. Ketamine-induced rotation: interaction with GABA-transaminase inhibitors and picrotoxin. Pharmacol Biochem Behav 1979;11:483-6.
104. Myslobodsky MS, Kofman O. A steroid derivative, R5135, activates long-lasting non-convulsant spiking in rats. Neuropharmacology 1983;22:157-64.
105. Myslobodsky MS, Kofman O, Mintz M. Convulsant-specific architecture of the postictal behavior syndrome in the rat. Epilepsia 1981;22:559-68.
106. Myslobodsky MS, Levin D. Visual evoked potentials in rats selected for high or low self-stimulation. Behav Brain Res 1984;11:145-53.
107. Myslobodsky MS, Levin D, Morag M. Anti-epileptic effects of amphetamine may require GABA (benzodiazepine) activity. Life Sci 1984;34:1391-6.
108. Myslobodsky MS, Mansour R. Hypersynchronization and sedation produced by GABA-transaminase inhibitors and picrotoxin: does GABA participate in sleep control? Waking and Sleeping 1979;3:245- 54.
109. Myslobodsky MS, Morag M. Suppression by sodium valproate of vinyl GABA-induced facilitation of visual evoked potentials in rats. Electroencephalogr Clin Neurophysiol 1981a;52:445-50.
110. Myslobodsky MS, Morag M. Pharmacologic analysis of sodium valproate-induced suppression of secondary components of visual evoked potentials in albino rats. Pharmacol Biochem Behav 1981b;15:601-5.
111. Myslobodsky MS, Valenstein ES. Amygdaloid kindling and the GABA system. Epilepsia 1980;21:163-75.
112. Orren MM. Visuomotor behavior and visual evoked potentials during petit mal seizures. Unpublished Ph.D. dissertation, 1974.
113. Orren MM. Evoked potential studies in petit mal epilepsy: visual information processing in relation to spike and wave discharges. Electroencephalogr Clin Neurophysiol 1978;34(Suppl):251-7.
114. Palacios JM, Kuhar MJ, Rapoport SI, London ED. Effects of aminobutyric acid agonists and antagonist drugs on local cerebral glucose utilization. J Neurosci 1982;2:853-60.
115. Pedley TA, Horton RW, Meldrum BS. Electroencephalographic and behavioral effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, Papio papio. Epilepsia 1979;20:409-16.
116. Penfield W, Jasper M, eds. Epilepsy and the functional anatomy of the human brain. Boston: Little, Brown, 1954.
117. Pole P, Bonetti EP, Schaffner R, Haefely W. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, carbolines and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol 1982;321:260-4.
118. Pollen DA. Experimental spike and wave responses in petit mal epilepsy. Epilepsia 1968;9:221.
119. Prince DA, Farrell D. Centrencephalic spike-wave discharges following parenteral penicillin injection in the cat. Neurology 1969;19:309-10.
120. Quesney LF. Dopamine and generalized photosensitive epilepsy. In: Morselli PL, Lloyd KG, Lscher W, Meldrum B, Reynolds EH, eds. Neurotransmitters, seizures, and epilepsy. New York: Raven Press, 1981:263-74.
121. Quesney LF, Andermann F, Lal S, Prelevic S. Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist. Neurology 1980;30:1169-74.
122. Raskin NH, Fishman MA. Neurological disorders of renal failure. N Engl J Med 1977;294:208-10.
123. Redmond DE Jr, Huang YM. New evidence for a locus ceruleus-norepinephrine connection with anxiety. Life Sci 1979;25:2149-62.
124. 3H] diazepam binding in vitro: correlation with convulsant potency. Eur J Pharmacol 1982;78:353-6.
125. Roberts E. Prospectus. Epilepsy and anti-epileptic drugs: a speculative synthesis. In: Glaser GH, Penry JK, Woodbury DM, eds. Anti-epileptic drugs: mechanisms of action. New York: Raven Press, 1980: 667-713.
126. Rodin E, Gonzales S, Caldwell D, Laginess D. Photic evoked responses during induced epileptic seizures. Epilepsia 1966;7:202-14.
127. Rosvold ME, Mirsky AF, Sarason I, Bransome ED, Beck LM. A continuous performance test of brain damage. J Consult Clin Psychol 1956;20:343-50.
128. Rushton R, Steinberg M. Combined effect of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment. Nature 1966;211:1312-3.
129. Sato S, Dreifuss FE, Penry JK. Prognostic factors in absence seizures. Neurology 1976;26:788-96.
130. Schwab RS. A method of measuring consciousness in petit mal epilepsy. J Nerv Ment Dis 1939;89:690-1.
131. Schwab RS. The influence of visual and auditory stimuli on the electroencephalographic tracing of petit mal. Am J Psychiatry 1941;97:1301-16.
132. Schwab RS. Reaction time in petit mal epilepsy. Res Publ Assoc Res Nerv Ment Dis 1947;26:339.
133. Scotti de Carolis A, Lipparini F, Losyo VG. Neuropharmacological investigations on muscimol, a psychotropic drug extracted from Amantia muscaria. Psychopharmacology 1969;15:186-95.
134. Selverton A. Are central pattern generators understandable? Behav Brain Sci 1980;3:565-71.
135. Seki T, Kawahara Y, Hirose M. The long-term prognosis of minor seizures in childhood epilepsy. Folia Psychiatr Neurol Jpn 1977;31:315-26.
136. Shearer DE, Fleming DE, Bigler ED. The photically evoked afterdischarge: a model for the study of drugs useful in the treatment of petit mal epilepsy. Epilepsia 1976;17:429-35.
137. Shimazono Y, Hirai T, Okuma T, Fukuda T, Yamamasu E. Disturbance of consciousness in petit mal epilepsy. Epilepsia 1953;2:49-55.
138. Siegel A, Grady CL, Mirsky AF. Prediction of spike-wave bursts in absence epilepsy by EEG power-spec- trum signals. Epilepsia 1982;23:47-60.
139. Siegel A, Mirsky AF. Prediction of petit mal seizures by EEG power-spectrum signals. Neurosci Abstr 1976;2:276.
140. Siegel A, Mirsky AF, Grady CL. A predictor of spike-wave bursts in petit mal EEG. Electroencephalogr Clin Neurophysiol 1979;46:8.
141. Siegel A, Mirsky AF, Grady CL. A predictor of spike-wave bursts in petit mal EEG II. Electroencephalogr Clin Neurophysiol 1980;49:24-5.
142. Snead OC. Gamma hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral and pharmacokinetic studies. Neurology 1978a;28:636-42.
143. Snead OC. Gamma hydroxybutyrate in the monkey. II. Effect of chronic oral anticonvulsant drugs. Neurology 1978;28:643-8.
144. Snead OC III, Bearden LJ. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine- enkephalin. Science 1980a;210:1031-3.
145. Snead OC III, Bearden LJ. Naloxone overcomes the dopaminergic, EEG and behavioral effects of gamma- hydroxybutyrate. Neurology 1980;30:832-8.
146. Snider WD, DeMaria AA Jr, Mann JD. Diazepam and dialysis encephalopathy. Neurology 1979;29:414- 5.
147. Sprick U, Oitzl MS, Ornstein K, Huston JP. Spreading depression induced by microinjection of enkephalins into the hippocampus and neocortex. Brain Res 1981;210:243-52.
148. Sterman MB, Friar L. Suppression of seizures in an epileptic following sensorimotor EEG feedback training. Electroencephalogr Clin Neurophysiol 1972;33:89-95.
149. Sterman MB, MacDonald LR. Effects of central cortical EEG feedback training on incidence of controlled seizures. Epilepsia 1978;19:207-22.
150. Stevens JR, Nakamura Y, Milstein V, Okuma P, Llinas R. Central and peripheral factors in epileptic discharge. Arch Neurol 1964;11:463.
151. Tizard B, Margerison JM. The relationship between generalized paroxysmal discharges and various test situations in two epileptic patients. J Neurol Neurosurg Psychiatry 1963a;26:308-13.
152. Tizard B, Margerison JM. Psychological functions during spike-wave discharge. Br J Soc Clin Psychol 1963b;3:6-15.
153. Trauner DA, Clayman M. Dialysis encephalopathy treated with clonazepam. Am Neurol 1979;6:555-6.
154. Trimble MR, Thompson PJ. Sodium valproate and cognitive function. Epilepsia 1984;25(Suppl 1):S60-4.
155. Vickers MD. Gamma-hydroxybutyrate. Int Anesthesiol Clin 1969;7:75-89.
156. Weir B. Spikes-wave from stimulation of the reticular core. Arch Neurol 1964;11:209-18.
157. Willmore LJ, Sypert GW, Munson JB, Hurd RW. Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science 1978;200:1501-2.
158. Winters WD, Spooner CE. A neurophysiological comparison of gamma-hydroxybutyrate with pentobarbital in cats. Electroencephalogr Clin Neurophysiol 1965;18:287-96.
159. Woodward DJ, Moiser MC, Waterhouse BD, Hoffer BJ, Freedman R. Modulatory action of norepinephrine in the central nervous system. Fed Proc 1979;38:2109-16.
160. Wyler AR, Robbine CA, Dodrill CB. EEG operant conditioning for control of epilepsy. Epilepsia 1979; 20:279-86.
161. Yamada Y, Yamamoto J, Fujiki A, Hishikawa Y, Keneko Z. Effects of butyrolactone and gamma-hydroxy- butyrate on the EEG and sleep cycle in man. Electroencephalogr Clin Neurophysiol 1967;22:538-62.
162. Yeager CL, Guerrant JS. Subclinical epileptic seizures, impairment of motor performance and derivative difficulties. California Med 1957;86:242-7.